These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27431728)

  • 1. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
    Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
    Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
    Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
    Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
    Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
    Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
    Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
    Dey P; Son JY; Kundu A; Kim KS; Lee Y; Yoon K; Yoon S; Lee BM; Nam KT; Kim HS
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.
    Conceição AL; Da Silva CT; Badial RM; Valsechi MC; Stuqui B; Gonçalves JD; Jasiulionis MG; De Freitas Calmon M; Rahal P
    Oncol Rep; 2017 Mar; 37(3):1487-1496. PubMed ID: 28184927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin promotes glucose consumption via regulation of miR-99a/mTOR/PKM2 pathway.
    Li W; Wang J; Chen QD; Qian X; Li Q; Yin Y; Shi ZM; Wang L; Lin J; Liu LZ; Jiang BH
    PLoS One; 2013; 8(6):e64924. PubMed ID: 23762265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
    Liu AM; Xu Z; Shek FH; Wong KF; Lee NP; Poon RT; Chen J; Luk JM
    PLoS One; 2014; 9(1):e86872. PubMed ID: 24466275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressive microRNA‑429 regulates cellular function by targeting VEGF in clear cell renal cell carcinoma.
    Chen D; Li Y; Li Y; Jin L; Su Z; Yu Z; Yang S; Mao X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1361-6. PubMed ID: 26647818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
    Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
    Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
    Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
    Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
    Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG
    Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKM2 contributes to cancer metabolism.
    Wong N; Ojo D; Yan J; Tang D
    Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.